Radiation Medicine Rounds is a trinary hard cover periodical designed to provide
an up-to- date review of a dedicated radiation medicine topic of interest to
clinicians and scientists who are involved in the care of patients receiving
radiotherapy. It is intended to serve as both a reference and instructional
tool for students, housestaff, fellows, practicing clinicians, medical physicists,
cancer biologists, radiobiologists, and interdisciplinary colleagues throughout
the oncology spectrum.
This issue of Radiation Medicine Rounds discusses the more salient topics surrounding the role of radiation therapy for hematologic malignancies.
There are literally dozens of distinct lymphoma subtypes, each with its own unique molecular and clinical features. Although systemic cytotoxic and targeted therapies have improved dramatically, radiation therapy remains an important modality for optimal clinical outcomes. With contributions from nationally recognized experts, Hematologic Malignancies offers an overview of the full spectrum of therapy for hematologic malignancies ranging from lymphoma and leukemia to plasma cell dyscrasias. Recent advances in radiotherapy for hematologic malignancies allow for maintenance of excellent local control with improvements in toxicity achieved through reductions in field sizes, in dose delivered, and increasingly conformal delivery techniques.Hematologic Malignancies provides the practitioner with a current overview of best practices, recent research, and future directions in the management of these complex cancers.
1. Hodgkin's early and advanced; 2. Diffuse Large B cell nodal and extranodal; 3. Follicular lymphoma; 4. Marginal zone lymphoma; 5. Cutaneous T cell lymphoma; 6. NK cell lymphoma; 7. Mantle cell lymphoma and other aggressive lymphomas; 8. Leukemia including lymphomblastic lymphoma; 9. Plasma cell dyscrasias; 10. PET in lymphoma; 11.Radioimmunotherapy; 12. Radiation and transplant
About the Guest Editors
- Michael Tomblyn, MD, MS Assistant Member Radiation Oncology Moffitt Cancer Center & Research Institute, Tampa FL
- Karen Winkfield, MD, PhD, Hematologic Malignancy Service, Department of Radiation Oncology, Massachusetts General Hospital
- Bouthaina S. Dabaja, MD, Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
- Charles R. Thomas Jr., MD, Professor and Chair, Department of Radiation Medicine, Professor, Division of Hematology/Oncology, Department of Medicine, Knight Cancer Institute, Oregon Health Sciences University, Portland, Oregon